At a glance
ClinicalIndex Comparison RecordN/ACompleted· 47 enrolled
Drug / intervention
X-Seal 6F Vascular Closure Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
X-Seal 6F Vascular Closure Device EU Post-Market Clinical Follow-Up Protocol
In Brief
A clinical study evaluating X-Seal 6F Vascular Closure Device for Femoral Arteriotomy Closure. Completed, enrolled 47 participants across 2 sites.
Detailed Summary
The study is designed to prospectively collect data on and confirm the safety and effectiveness of the X-Seal 6F Vascular Closure System in reducing time to hemostasis and time to ambulation for patients who have undergone diagnostic or interventional catheterization procedures using up to 6F sheaths when compared with standard compression techniques using data from literature surveys.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFemoral Arteriotomy Closure
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartApr 2015
First PostedApr 2015
Primary CompletionFeb 2016
Study CompletionJun 2016
TodayJul 2026
First PostedApr 2, 2015
Enrollment StartApr 1, 2015
Primary CompletionFeb 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.3 years ago
Interventions
X-Seal 6F Vascular Closure Devicedevice